Page last updated: 2024-08-16

timolol and glanatec

timolol has been researched along with glanatec in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Abe, H; Araie, M; Inoue, T; Kuwayama, Y; Suganami, H; Tanihara, H; Yamamoto, T	1
Inoue, K; Ishida, K; Tomita, G	1
Hirooka, K; Kiuchi, Y; Ko, JA; Komatsu, K; Kondo, S; Minamoto, A; Okumichi, H	1

Trials

1 trial(s) available for timolol and glanatec

Article	Year
Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials. JAMA ophthalmology, 2015, Volume: 133, Issue:7 Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Isoquinolines; Japan; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; rho-Associated Kinases; Severity of Illness Index; Sulfonamides; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome	2015

Article

Year

Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.

JAMA ophthalmology, 2015, Volume: 133, Issue:7

Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Isoquinolines; Japan; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; rho-Associated Kinases; Severity of Illness Index; Sulfonamides; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome

2015

Other Studies

2 other study(ies) available for timolol and glanatec

Article	Year
Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil. Japanese journal of ophthalmology, 2018, Volume: 62, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Isoquinolines; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; rho-Associated Kinases; Sulfonamides; Timolol; Treatment Outcome	2018
Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery. Current eye research, 2023, Volume: 48, Issue:9 Topics: Animals; Antiglaucoma Agents; Cicatrix; Collagen; Fibroblasts; Filtering Surgery; Glaucoma; Humans; Latanoprost; Mice; Protein Kinase Inhibitors; rho-Associated Kinases; Timolol; Transforming Growth Factor beta; Vimentin	2023

Article

Year

Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil.

Japanese journal of ophthalmology, 2018, Volume: 62, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Isoquinolines; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; rho-Associated Kinases; Sulfonamides; Timolol; Treatment Outcome

2018

Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.

Current eye research, 2023, Volume: 48, Issue:9

Topics: Animals; Antiglaucoma Agents; Cicatrix; Collagen; Fibroblasts; Filtering Surgery; Glaucoma; Humans; Latanoprost; Mice; Protein Kinase Inhibitors; rho-Associated Kinases; Timolol; Transforming Growth Factor beta; Vimentin

2023